These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma. Teal L; Yorio J Case Rep Oncol Med; 2021; 2021():8870334. PubMed ID: 33859852 [TBL] [Abstract][Full Text] [Related]
23. Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan. Hofmann H; von Haken R; Werner J; Kortes N; Bergmann F; Schemmer P; Jäger D; Radeleff B; Schulze-Bergkamen H Pancreatology; 2014; 14(6):546-9. PubMed ID: 25280592 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of chemosaturation in patients with hepatic metastases from uveal melanoma. Estler A; Artzner C; Bitzer M; Nikolaou K; Hoffmann R; Hepp T; Hagen F; Eigentler T; Forschner A; Grözinger G Acta Radiol; 2022 May; 63(5):577-585. PubMed ID: 34034537 [TBL] [Abstract][Full Text] [Related]
25. Saphenous vein graft percutaneous coronary intervention via radial artery access: safe and effective with reduced hospital length of stay. Bundhoo SS; Earp E; Ivanauskiene T; Kunadian V; Freeman P; Edwards R; Kinnaird TD; Zaman A; Anderson RA Am Heart J; 2012 Oct; 164(4):468-72. PubMed ID: 23067903 [TBL] [Abstract][Full Text] [Related]
26. Selective Internal Radiotherapy (SIRT) and Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) for Metastasized Uveal Melanoma: A Retrospective Comparative Study. Kolb M; Forschner A; Artzner C; Grözinger G; Said I; Dittmann H; Seith F Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894309 [TBL] [Abstract][Full Text] [Related]
27. Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases. Hughes MS; Zager J; Faries M; Alexander HR; Royal RE; Wood B; Choi J; McCluskey K; Whitman E; Agarwala S; Siskin G; Nutting C; Toomey MA; Webb C; Beresnev T; Pingpank JF Ann Surg Oncol; 2016 Apr; 23(4):1309-19. PubMed ID: 26597368 [TBL] [Abstract][Full Text] [Related]
28. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience. Forster MR; Rashid OM; Perez MC; Choi J; Chaudhry T; Zager JS J Surg Oncol; 2014 Apr; 109(5):434-9. PubMed ID: 24249545 [TBL] [Abstract][Full Text] [Related]
29. Percutaneous femoral implantation of an arterial port catheter for intraarterial chemotherapy: feasibility and predictive factors of long-term functionality. Deschamps F; Rao P; Teriitehau C; Hakime A; Malka D; Boige V; Ducreux M; Elias D; Goere D; de Baere T J Vasc Interv Radiol; 2010 Nov; 21(11):1681-8. PubMed ID: 21029950 [TBL] [Abstract][Full Text] [Related]
30. Analysis of patient's X-ray exposure in hepatic chemosaturation procedures: a single center experience. Ebel S; Reinhardt M; Beeskow AB; Teske F; Struck MF; Veelken R; van Boemmel F; Berg T; Moche M; Gutberlet M; Gößmann H; Denecke T BMC Med Imaging; 2022 Sep; 22(1):165. PubMed ID: 36100850 [TBL] [Abstract][Full Text] [Related]
31. Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan. Struck MF; Werdehausen R; Kirsten H; Gössmann H; Veelken R; van Bömmel F; Stehr S; Denecke T; Ebel S Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568592 [TBL] [Abstract][Full Text] [Related]
32. Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver. de Leede EM; Burgmans MC; Martini CH; Tijl FG; van Erkel AR; Vuyk J; Kapiteijn E; Verhoef C; van de Velde CJ; Vahrmeijer AL J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501370 [TBL] [Abstract][Full Text] [Related]
33. Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma. Meijer TS; Geus-Oei LF; Martini CH; Tijl FGJ; Sitsen ME; Erkel ARV; Meer RWV; Kapiteijn E; Vahrmeijer AL; Burgmans MC Diagn Interv Radiol; 2019 Nov; 25(6):451-458. PubMed ID: 31650973 [TBL] [Abstract][Full Text] [Related]
34. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of percutaneous unilateral trans-femoral implantation of side-hole port-catheter system with coil only fixed-catheter-tip for hepatic arterial infusion chemotherapy. Hu J; Zhu X; Wang X; Cao G; Wang X; Yang R Cancer Imaging; 2019 Mar; 19(1):15. PubMed ID: 30885278 [TBL] [Abstract][Full Text] [Related]
36. Vascular Interventions in Oncology. Osman A; Patel S; Gonsalves M; Renani S; Morgan R Clin Oncol (R Coll Radiol); 2024 Aug; 36(8):473-483. PubMed ID: 37805354 [TBL] [Abstract][Full Text] [Related]
37. [The percutaneous placement of intra-arterial catheters with "reservoirs" for subcutaneous infusion. The technic and preliminary results]. Grosso M; Zanon C; Zanon E; Corsico M; Gazzera C; Mancini A; Fava C Radiol Med; 1997 Sep; 94(3):226-32. PubMed ID: 9446130 [TBL] [Abstract][Full Text] [Related]
38. [Thrombotic occlusion of the extracorporeal circulation during hepatic chemosaturation despite targeted anticoagulation : A case report]. Kuhner M; Tan B; Fiedler MO; Biecker O; Klein B; Chang DH; Weigand MA; Dietrich M Anaesthesiologie; 2022 Nov; 71(11):852-857. PubMed ID: 35925192 [TBL] [Abstract][Full Text] [Related]
39. Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan-Long-Term Overall Survival Negatively Correlates with Tumor Burden. Brüning R; Tiede M; Schneider M; Wohlmuth P; Weilert H; Oldhafer K; Stang A Radiol Res Pract; 2020; 2020():5672048. PubMed ID: 32934846 [TBL] [Abstract][Full Text] [Related]
40. A simplified technique of percutaneous hepatic artery port-catheter insertion for the treatment of advanced hepatocellular carcinoma with portal vein invasion. Choi SY; Kim AH; Kim KA; Won JY; Lee DY; Lee KH Korean J Radiol; 2010; 11(6):648-55. PubMed ID: 21076591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]